// App-Quantinova.ai

3323 : Clinicopathological Study Of 12 Cases Of EBV-Associated Post-Transplant Lymphoproliferative Disorder (PTLD) After Allogeneic SCT: A Single Institution Analysis Of 825 Transplants Including 572 Cord Blood Transplants In Toranomon Hospital

Researchers

Presenter

  • Daisuke Kaji

Principal Investigators

  • Yasunori Ota

  • Aya Nishida

  • Koji Izutsu

  • Shuichi Taniguchi

  • Hisashi Yamamoto

  • Hikari Ota

  • Kazuya Ishiwata

  • Masanori Tsuji

  • Go Yamamoto

  • Yuki Asano-Mori

  • Naoyuki Uchida

  • Atsushi Wake

Medical Centers

  • Toranomon Hospital, Tokyo, Japan

  • Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo, Japan

  • Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa,

  • Department of Hematology, Toranomon Hospital, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Post-transplant lymphoproliferative disorder

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Chronic Myelogenous Leukemia

  • Acute myelocytic leukemia

  • Aplastic anemia

  • Lymphomas

  • Anemia

Biomarkers

  • PDZ And LIM Domain 7

Drug/Treatment

  • fludarabine tablet

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved